SCYX logo

SCYNEXIS (SCYX) EBITDA

Annual EBITDA

$70.89 M
+$132.59 M+214.88%

December 31, 2023

Summary

Performance

1-Year Change

+214.88%

3-Year Change

+224.28%

5-Year Change

+504.5%

15-Year Change

+406.03%

SCYX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

86.49%
SCYX annual EBITDA is higher than 86.49% of companies in Healthcare sector

High & Low

All-time High

$70.89 M
SCYX annual EBITDA is currently at an all-time high

3-Year Low

-$61.70 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SCYX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 28, 2025
SCYX next annual earnings announcement is scheduled for Mar 28, 2025

OtherSCYXprofitabilitymetrics:

Annual Revenue

$140.14 M
SCYX annual revenue is $140.14 million

Annual Net Income

$67.04 M
SCYX annual net profit is $67.04 million

Annual EBIT

$70.31 M
SCYX annual earnings before interest & taxes is $70.31 million

Annual EPS

$1.39
SCYX annual earnings per share is $1.39

Quarterly EBITDA

-$2.99 M
+$11.27 M+79.03%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

SCYX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

57.18%
SCYX quarterly EBITDA is higher than 57.18% of companies in Healthcare sector

High & Low

All-time High

$123.66 M
SCYX quarterly EBITDA is currently -102.42% below its historical high of $123.66 million

3-Year Low

-$32.28 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SCYX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
SCYX next earnings announcement is scheduled for Mar 28, 2025

OtherSCYXprofitabilitymetrics:

Quarterly Revenue

$660.00 K
SCYX quarterly revenue is $660.00 thousand

Quarterly Net Income

-$2.81 M
SCYX quarterly net profit is -$2.81 million

Quarterly EBIT

-$2.99 M
SCYX quarterly earnings before interest & taxes is -$2.99 million

Quarterly EPS

-$0.06
SCYX quarterly earnings per share is -$0.06

TTM EBITDA

-$35.20 M
-$1.59 M-4.74%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

SCYX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

38.85%
SCYX TTM EBITDA is higher than 38.85% of companies in Healthcare sector

High & Low

All-time High

$104.31 M
SCYX TTM EBITDA is currently -133.75% below its historical high of $104.31 million

3-Year Low

-$85.05 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SCYX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
SCYX next earnings announcement is scheduled for Mar 28, 2025

OtherSCYXprofitabilitymetrics:

TTM Revenue

$8.57 M
SCYX TTM revenue is $8.57 million

TTM Net Income

-$36.44 M
SCYX TTM net profit is -$36.44 million

TTM EBIT

-$35.33 M
SCYX TTM earnings before interest & taxes is -$35.33 million

TTM EPS

-$0.76
SCYX TTM earnings per share is -$0.76

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$70.89 M
SCYX annual EBITDA is $70.89 million

Annual Net Income

$67.04 M
SCYX annual net profit is $67.04 million

Annual Interest Expense

$3.13 M
SCYX annual interest expense is $3.13 million

Annual Income Tax

$138.00 K
SCYX annual income tax is $138.00 thousand

Annual D&A

$580.00 K
SCYX annual depreciation & amortization is $580.00 thousand

SCYX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+214.9%0.0%0.0%
3 y3 years+224.3%0.0%0.0%
5 y5 years+504.5%0.0%0.0%

SCYX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+214.9%-102.4%+90.7%-133.8%+58.6%
5 y5-yearat high+214.9%-102.4%+92.9%-133.8%+58.6%
alltimeall timeat high+214.9%-102.4%+92.9%-133.8%+58.6%

SCYNEXIS EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$2.99 M(-79.0%)
-$35.20 M(+4.7%)
Jun 2024
-
-$14.26 M(-1343.3%)
-$33.61 M(-132.2%)
Mar 2024
-
$1.15 M(-106.0%)
$104.31 M(+47.2%)
Dec 2023
$70.89 M(-214.9%)
-$19.10 M(+1266.0%)
$70.89 M(-8.2%)
Sep 2023
-
-$1.40 M(-101.1%)
$77.24 M(+52.7%)
Jun 2023
-
$123.66 M(-483.1%)
$50.58 M(-159.5%)
Mar 2023
-
-$32.28 M(+153.3%)
-$85.05 M(+37.8%)
Dec 2022
-$61.70 M(+87.5%)
-$12.74 M(-54.6%)
-$61.70 M(-19.8%)
Sep 2022
-
-$28.05 M(+134.4%)
-$76.97 M(+58.7%)
Jun 2022
-
-$11.97 M(+33.9%)
-$48.51 M(+25.9%)
Mar 2022
-
-$8.94 M(-68.1%)
-$38.52 M(+17.0%)
Dec 2021
-$32.91 M(-42.3%)
-$28.02 M(-6899.8%)
-$32.91 M(-30.4%)
Sep 2021
-
$412.00 K(-120.8%)
-$47.26 M(+1.8%)
Jun 2021
-
-$1.98 M(-40.7%)
-$46.41 M(-13.4%)
Mar 2021
-
-$3.33 M(-92.1%)
-$53.61 M(-6.0%)
Dec 2020
-$57.04 M(+8.4%)
-$42.36 M(-3443.6%)
-$57.04 M(+97.4%)
Sep 2020
-
$1.27 M(-113.8%)
-$28.90 M(-23.7%)
Jun 2020
-
-$9.18 M(+35.7%)
-$37.88 M(+2.8%)
Mar 2020
-
-$6.76 M(-52.4%)
-$36.86 M(-29.9%)
Dec 2019
-$52.61 M(+200.2%)
-$14.22 M(+84.4%)
-$52.61 M(+23.1%)
Sep 2019
-
-$7.71 M(-5.5%)
-$42.73 M(+24.9%)
Jun 2019
-
-$8.16 M(-63.7%)
-$34.22 M(-5.8%)
Mar 2019
-
-$22.51 M(+418.1%)
-$36.31 M(+109.7%)
Dec 2018
-$17.52 M
-$4.34 M(-641.1%)
-$17.31 M(-13.8%)
DateAnnualQuarterlyTTM
Sep 2018
-
$803.00 K(-107.8%)
-$20.08 M(-30.3%)
Jun 2018
-
-$10.26 M(+192.2%)
-$28.81 M(+29.5%)
Mar 2018
-
-$3.51 M(-50.7%)
-$22.25 M(-3.9%)
Dec 2017
-$23.16 M(-21.5%)
-$7.12 M(-10.2%)
-$23.17 M(+21.7%)
Sep 2017
-
-$7.93 M(+114.2%)
-$19.03 M(-14.8%)
Jun 2017
-
-$3.70 M(-16.3%)
-$22.33 M(-16.5%)
Mar 2017
-
-$4.42 M(+48.3%)
-$26.75 M(-9.3%)
Dec 2016
-$29.51 M(+5.8%)
-$2.98 M(-73.4%)
-$29.51 M(-15.5%)
Sep 2016
-
-$11.22 M(+38.2%)
-$34.92 M(+11.8%)
Jun 2016
-
-$8.12 M(+13.1%)
-$31.23 M(+6.0%)
Mar 2016
-
-$7.18 M(-14.4%)
-$29.48 M(+5.6%)
Dec 2015
-$27.90 M(+408.9%)
-$8.39 M(+11.3%)
-$27.90 M(+87.2%)
Sep 2015
-
-$7.54 M(+18.3%)
-$14.90 M(+28.5%)
Jun 2015
-
-$6.37 M(+13.5%)
-$11.60 M(+29.8%)
Mar 2015
-
-$5.61 M(-221.7%)
-$8.94 M(+86.1%)
Dec 2014
-$5.48 M(-68.2%)
$4.61 M(-208.9%)
-$4.80 M(-75.7%)
Sep 2014
-
-$4.24 M(+14.3%)
-$19.79 M(+4.7%)
Jun 2014
-
-$3.71 M(+151.6%)
-$18.89 M(+9.4%)
Mar 2014
-
-$1.47 M(-85.8%)
-$17.27 M(+0.2%)
Dec 2013
-$17.25 M(+91.3%)
-$10.37 M(+210.1%)
-$17.25 M(+150.9%)
Sep 2013
-
-$3.34 M(+60.4%)
-$6.88 M(+94.7%)
Jun 2013
-
-$2.08 M(+44.2%)
-$3.53 M(+144.2%)
Mar 2013
-
-$1.45 M
-$1.45 M
Dec 2012
-$9.02 M
-
-

FAQ

  • What is SCYNEXIS annual EBITDA?
  • What is the all time high annual EBITDA for SCYNEXIS?
  • What is SCYNEXIS annual EBITDA year-on-year change?
  • What is SCYNEXIS quarterly EBITDA?
  • What is the all time high quarterly EBITDA for SCYNEXIS?
  • What is SCYNEXIS quarterly EBITDA year-on-year change?
  • What is SCYNEXIS TTM EBITDA?
  • What is the all time high TTM EBITDA for SCYNEXIS?
  • What is SCYNEXIS TTM EBITDA year-on-year change?

What is SCYNEXIS annual EBITDA?

The current annual EBITDA of SCYX is $70.89 M

What is the all time high annual EBITDA for SCYNEXIS?

SCYNEXIS all-time high annual EBITDA is $70.89 M

What is SCYNEXIS annual EBITDA year-on-year change?

Over the past year, SCYX annual EBITDA has changed by +$132.59 M (+214.88%)

What is SCYNEXIS quarterly EBITDA?

The current quarterly EBITDA of SCYX is -$2.99 M

What is the all time high quarterly EBITDA for SCYNEXIS?

SCYNEXIS all-time high quarterly EBITDA is $123.66 M

What is SCYNEXIS quarterly EBITDA year-on-year change?

Over the past year, SCYX quarterly EBITDA has changed by $0.00 (0.00%)

What is SCYNEXIS TTM EBITDA?

The current TTM EBITDA of SCYX is -$35.20 M

What is the all time high TTM EBITDA for SCYNEXIS?

SCYNEXIS all-time high TTM EBITDA is $104.31 M

What is SCYNEXIS TTM EBITDA year-on-year change?

Over the past year, SCYX TTM EBITDA has changed by $0.00 (0.00%)